Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name PD-0325901
Trade Name
Synonyms PD0325901|PD 0325901|PD-901|Mirdametinib
Drug Descriptions

PD-0325901, a derivative of CI-1040, is a pan-MEK inhibitor, which inhibits activation of MAPK/ERK resulting in decreased tumor cell proliferation (PMID: 18952427, PMID: 32147669).

DrugClasses MEK inhibitor (Pan) 26 MEK1 Inhibitor 26 MEK2 Inhibitor 24
CAS Registry Number 391210-10-9
NCIT ID C52195

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Apitolisib + PD-0325901 Apitolisib PD-0325901 0 0
APS-2-79 + PD-0325901 APS-2-79 PD-0325901 0 0
Azacitidine + PD-0325901 Azacitidine PD-0325901 0 0
BGB3245 + PD-0325901 BGB3245 PD-0325901 0 1
BI2536 + PD-0325901 BI2536 PD-0325901 0 0
Dacomitinib + PD-0325901 Dacomitinib PD-0325901 0 0
Dactolisib + PD-0325901 Dactolisib PD-0325901 0 0
Deucravacitinib + PD-0325901 Deucravacitinib PD-0325901 0 0
Fulvestrant + PD-0325901 Fulvestrant PD-0325901 0 0
Gedatolisib + PD-0325901 Gedatolisib PD-0325901 0 0
Lifirafenib + PD-0325901 Lifirafenib PD-0325901 3 1
Palbociclib + PD-0325901 PD-0325901 Palbociclib 4 1
Palbociclib + PD-0325901 + unspecified PD-L1 antibody PD-0325901 Palbociclib unspecified PD-L1 antibody 0 0
PD-0325901 PD-0325901 17 4
PD-0325901 + PF-04691502 PD-0325901 PF-04691502 0 0
PD-0325901 + Pictilisib PD-0325901 Pictilisib 1 0
PD-0325901 + Radiotherapy PD-0325901 Radiotherapy 1 0
PD-0325901 + Sapanisertib PD-0325901 Sapanisertib 4 0
PD-0325901 + Sorafenib PD-0325901 Sorafenib 2 0
PD-0325901 + Sotorasib PD-0325901 Sotorasib 0 0
PD-0325901 + Sotrastaurin PD-0325901 Sotrastaurin 0 0
PD-0325901 + ZSTK474 PD-0325901 ZSTK474 0 0


Additional content available in CKB BOOST